✦ LIBER ✦

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

✍ Scribed by Guruprasad P. Aithal; James A. Thomas; Philip V. Kaye; Adam Lawson; Stephen D. Ryder; Ian Spendlove; Andrew S. Austin; Jan G. Freeman; Linda Morgan; Jonathan Webber

Book ID: 119760482
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 374 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.06.047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Placebo-Controlled Trial of

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

✍ Guruprasad P. Aithal; James A. Thomas; Philip V. Kaye; Adam Lawson; Stephen D. R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 374 KB

A Placebo-Controlled Trial of Pioglitazo

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

✍ Belfort, Renata; Harrison, Stephen A.; Brown, Kenneth; Darland, Celia; Finch, Jo 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 291 KB

Ursodeoxycholic acid for treatment of no

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized, placebo-controlled trial

✍ Lindor, Keith D. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 499 KB

A phase 2, randomized, double-blind, pla

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis

✍ Vlad Ratziu; Muhammad Y. Sheikh; Arun J. Sanyal; Joseph K. Lim; Hari Conjeevaram 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

In nonalcoholic steatohepatitis (NASH), the extent of hepatocyte apoptosis correlates with disease severity. Reducing hepatocyte apoptosis with the selective caspase inhibitor GS-9450 has a potential for altering the course of the liver disease. In this phase 2, double-blind study, 124 subjects with

Relationship between adipose tissue insu

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study

✍ Lauren N. Bell; Jiangxia Wang; Sriya Muralidharan; Sadhana Chalasani; Allison M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Rosiglitazone for Nonalcoholic Steatohep

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

✍ Vlad Ratziu; Philippe Giral; Sophie Jacqueminet; Fréderic Charlotte; Agnès Harte 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 479 KB